Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Rizzo

Showing results (101-110 of 131) with videos related to

Pageof 14
Sort By:
Neurology|April 10, 2021
In Vivo Diagnosis of Synucleinopathies: A Comparative Study of Skin Biopsy and RT-QuICVincenzo Donadio, Zerui Wang, Alex Incensi, et al.
Bioorganic & Medicinal Chemistry|May 9, 2012
Pyrazole[3,4-e][1,4]thiazepin-7-one derivatives as a novel class of Farnesoid X Receptor (FXR) agonistsMaura Marinozzi, Andrea Carotti, Emanuele Sansone, et al.
Annals of Clinical and Translational Neurology|August 29, 2025
Identification of Dementia With Lewy Bodies by Skin Biopsy in Recent-Onset Cognitive ImpairmentAlessandro Furia, Alex Incensi, Cecilia Delprete, et al.
Neuroimage. Clinical|March 13, 2018
Brain functional connectivity in sleep-related hypermotor epilepsyStefania Evangelisti, Claudia Testa, Lorenzo Ferri, et al.
Brain : a Journal of Neurology|October 22, 2008
Visual system involvement in patients with Friedreich's ataxiaFilippo Fortuna, Piero Barboni, Rocco Liguori, et al.
Molecular Pharmacology|July 16, 2010
Functional characterization of the semisynthetic bile acid derivative INT-767, a dual farnesoid X receptor and TGR5 agonistGiovanni Rizzo, Daniela Passeri, Francesca De Franco, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 15, 2003
Good safety profile and efficacy of leucocyte interferon-alpha in combination with oral ribavirin in treatment-naive patients with chronic hepatitis C: a multicentre, randomised, controlled studyGiuseppe Barbaro, Benvenuto Grisorio, Luigi Fruttaldo, et al.
Cell Metabolism|December 14, 2011
TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loadingThijs W H Pols, Mitsunori Nomura, Taoufiq Harach, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 4, 2011
Brain diffusion-weighted imaging in Friedreich's ataxiaGiovanni Rizzo, Caterina Tonon, Maria Lucia Valentino, et al.
Brain : a Journal of Neurology|May 13, 2022
Phosphorylated α-synuclein in skin Schwann cells: a new biomarker for multiple system atrophyVincenzo Donadio, Alex Incensi, Giovanni Rizzo, et al.
Pageof 14

Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
Neurology|April 10, 2021
In Vivo Diagnosis of Synucleinopathies: A Comparative Study of Skin Biopsy and RT-QuICVincenzo Donadio, Zerui Wang, Alex Incensi, et al.
Bioorganic & Medicinal Chemistry|May 9, 2012
Pyrazole[3,4-e][1,4]thiazepin-7-one derivatives as a novel class of Farnesoid X Receptor (FXR) agonistsMaura Marinozzi, Andrea Carotti, Emanuele Sansone, et al.
Annals of Clinical and Translational Neurology|August 29, 2025
Identification of Dementia With Lewy Bodies by Skin Biopsy in Recent-Onset Cognitive ImpairmentAlessandro Furia, Alex Incensi, Cecilia Delprete, et al.
Neuroimage. Clinical|March 13, 2018
Brain functional connectivity in sleep-related hypermotor epilepsyStefania Evangelisti, Claudia Testa, Lorenzo Ferri, et al.
Brain : a Journal of Neurology|October 22, 2008
Visual system involvement in patients with Friedreich's ataxiaFilippo Fortuna, Piero Barboni, Rocco Liguori, et al.
Molecular Pharmacology|July 16, 2010
Functional characterization of the semisynthetic bile acid derivative INT-767, a dual farnesoid X receptor and TGR5 agonistGiovanni Rizzo, Daniela Passeri, Francesca De Franco, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 15, 2003
Good safety profile and efficacy of leucocyte interferon-alpha in combination with oral ribavirin in treatment-naive patients with chronic hepatitis C: a multicentre, randomised, controlled studyGiuseppe Barbaro, Benvenuto Grisorio, Luigi Fruttaldo, et al.
Cell Metabolism|December 14, 2011
TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loadingThijs W H Pols, Mitsunori Nomura, Taoufiq Harach, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 4, 2011
Brain diffusion-weighted imaging in Friedreich's ataxiaGiovanni Rizzo, Caterina Tonon, Maria Lucia Valentino, et al.
Brain : a Journal of Neurology|May 13, 2022
Phosphorylated α-synuclein in skin Schwann cells: a new biomarker for multiple system atrophyVincenzo Donadio, Alex Incensi, Giovanni Rizzo, et al.
Pageof 14